Ambrx Biopharma Inc ADR (AMAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Sales | 7,402 | 7,455 | 13,671 | 10,311 | 0 |
| Gross Profit | 7,402 | 7,455 | 13,671 | 10,311 | N/A |
| Operating Expenses | 74,143 | 71,366 | 26,786 | 32,783 | 0 |
| Operating Income | -66,741 | -63,911 | -13,115 | -22,472 | N/A |
| Interest Expense | 968 | 0 | 0 | 0 | 0 |
| Other Income | -8,350 | -4,376 | -4,723 | 157 | 0 |
| Pre-tax Income | -76,059 | -68,287 | -17,838 | -22,315 | 0 |
| Income Tax | 1,937 | 1 | 1 | -2 | N/A |
| Net Income Continuous | -77,996 | -68,288 | -17,839 | -22,313 | N/A |
| Minority Interests | N/A | -209 | -1,296 | -2,251 | N/A |
| Net Income | $-77,996 | $-68,079 | $-16,543 | $-20,062 | $N/A |
| EPS Basic Total Ops | -2.02 | -3.33 | -0.98 | -1.05 | N/A |
| EPS Basic Continuous Ops | -2.02 | -3.34 | -1.08 | -1.15 | N/A |
| EPS Diluted Total Ops | -2.02 | -3.33 | -0.98 | -1.05 | N/A |
| EPS Diluted Continuous Ops | -2.02 | -3.34 | -1.08 | -1.15 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.29 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-65,448 | $-61,757 | $-11,172 | $-20,419 | $N/A |